- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.05. | 20/20 Biolabs Inc.: 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters | 3 | GlobeNewswire (USA) | ||
| 22.05. | 20/20 Biolabs: Pläne für Ebola-Tests treiben Aktie an | 1 | Investing.com Deutsch | ||
| 22.05. | 20/20 Biolabs Inc.: 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand | 2 | GlobeNewswire (USA) | ||
| 20.05. | 20/20 Biolabs, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 20.05. | 20/20 Biolabs, Inc. GAAP EPS of -$0.28 misses by $0.18, revenue of $0.35M misses by $0.43M | 1 | Seeking Alpha | ||
| 20.05. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | 20/20 Biolabs Inc.: 20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina | 1 | GlobeNewswire (USA) | ||
| 20/20 BIOLABS Aktie jetzt für 0€ handeln | |||||
| 28.04. | 20/20 Biolabs, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.04. | RedChip Companies, Inc.: BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 674 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc. (Nasdaq:AIDX), Society Pass Inc. (Nasdaq:SOPA)... ► Artikel lesen | |
| 07.04. | 20/20 Biolabs Inc.: 20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest for Cancer Through Evexia Platform | 2 | GlobeNewswire (USA) | ||
| 06.04. | 20/20 Biolabs, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 01.04. | 20/20 Biolabs, Inc. GAAP EPS of -$0.76, revenue of $2M | 1 | Seeking Alpha | ||
| 01.04. | 20/20 Biolabs, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | 20/20 Biolabs Inc.: 20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress | 224 | GlobeNewswire (Europe) | Full Year 2025 Revenue of $2.0 Million, up 17% from 2024 Gross Profit Increased 68% in FY 2025 and Gross Margin Expanded 900 bps State-Funded Firefighter Cancer Screening Program Expected to Drive... ► Artikel lesen | |
| 31.03. | 20/20 Biolabs, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 27.03. | 20/20 Biolabs Unchanged on News | 1 | Baystreet.ca | ||
| 27.03. | 20/20 Biolabs Inc.: Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test | 5 | GlobeNewswire (USA) | ||
| 24.03. | 20/20 Biolabs Inc.: 20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program | 425 | GlobeNewswire (Europe) | Inflammatory Biomarker Tracking Predicted to Enhance Response to 3-D Bio-Printed Therapies Expands OneTest for Longevity with Chronic Kidney Disease Risk Assessment GAITHERSBURG, Md., March 24,... ► Artikel lesen | |
| 12.03. | 20/20 Biolabs Inc.: 20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies | 1 | GlobeNewswire (USA) | ||
| 25.02. | 20/20 Biolabs Inc.: 20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities | 519 | GlobeNewswire (Europe) | Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 68,99 | +0,01 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,270 | +0,04 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 25,350 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| BILLIONTOONE | 120,41 | +0,01 % | BillionToOne, Inc. - 8-K, Current Report | ||
| LIFESTANCE HEALTH GROUP | 10,335 | -0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| HEARTFLOW | 34,860 | +0,03 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| PROGYNY | 28,860 | 0,00 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| GENEDX | 69,27 | +0,22 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| PROCEPT BIOROBOTICS | 22,590 | +0,04 % | Evercore Initiates PROCEPT BioRobotics (PRCT) At "Outperform," Cites Aquablation Growth Potential | ||
| RXSIGHT | 5,120 | +0,39 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,560 | +0,04 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 9,760 | -0,20 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| ONCOLOGY INSTITUTE | 5,605 | +0,09 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| INNOVAGE | 11,610 | 0,00 % | InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026 | DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,660 | 0,00 % | Aveanna Healthcare (AVAH) is a Great Momentum Stock: Should You Buy? |
20/20 BIOLABS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,591 Euro und damit -1,06 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 20/20 BIOLABS INC finden Sie auf Wallstreet Online.